Preliminary efficacy of pembrolizumab plus lenvatinib in recurrent clear cell gynecological cancer: Phase II LARA trial (GCGS-OV4/APGOT-OV3). - Byoung-Gie Kim; Chel Hun Choi; Ngoi, Natalie; Tan, David; Jae-Weon Kim (Journal of Gynecologic Oncology, 2024)